Alcon

What Alcon does

Alcon is the largest eye care device company in the world, organized into two complementary business segments: Surgical and Vision Care. The Surgical segment covers cataract, vitreoretinal, and refractive surgery products, including intraocular lenses (PanOptix, Vivity, Clareon families with 175M+ cumulative implants), phacoemulsification platforms (Unity CS/VCS, CENTURION), vitreoretinal systems (CONSTELLATION), visualization systems (NGENUITY 3D), surgical planning tools (ORA SYSTEM, ARGOS Biometer), and glaucoma devices (Hydrus Microstent, BELKIN Vision DSLT). The Vision Care segment spans daily disposable, reusable, and color contact lens brands (DAILIES TOTAL1, TOTAL30, PRECISION1, PRECISION7, AIR OPTIX), ocular health products (Systane, Pataday, Tryptyr, EYSUVIS, ROCKLATAN, RHOPRESSA), and lens care solutions (OPTI-FREE, CLEAR CARE). The portfolio rests on proprietary technologies including Water Gradient contact lens chemistry, Opti-Balance IOL design, ACTIV-FLO moisture technology, and DropTainer dispensing, supported by $990M in 2025 R&D and a 74+ product pipeline.

Alcon operates across 60 countries with direct presence and serves patients in more than 140 countries through a hybrid B2B and consumer go-to-market. Surgical products move through dedicated field sales teams to hospitals, ambulatory surgical centers, and ophthalmologists, while Vision Care products reach consumers through eye care professionals, retail pharmacies, and direct-to-consumer e-commerce (including the MARLO app). Revenue is generated primarily through unit pricing on hardware sales (IOLs, contact lenses, surgical equipment, pharmaceuticals) rather than software or recurring subscriptions. 2025 net sales were $10.3 billion, with Q1 2026 sales of $2.685 billion (up 10% reported, 6% constant currency). The company is publicly traded on NYSE and SIX Swiss Exchange under ticker ALC, having spun off from Novartis in April 2019, and employs 25,000+ associates globally across 17 manufacturing sites.

Name

Alcon

Legal name

Alcon Inc.

Website

https://alcon.com

Company type

Public

Founded year

1945

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Alcon is the largest global eye care device company, operating two segments — Surgical (IOLs, phaco systems, surgical equipment) and Vision Care (contact lenses, ocular health products) — serving surgeons and patients in 140+ countries with 2025 net sales of $10.3 billion.

Ownership category

akta.pro rank

Product category

Ophthalmic Devices and Vision Care Products

NAICS

Ophthalmic Goods Manufacturing (339115), Ophthalmic Goods Merchant Wholesalers (423460), Optical Goods Retailers (45613), Offices of Optometrists (62132)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)

akta.pro secondary industries

Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE), Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment) (HLAHAJAD), Comprehensive Eye Exams & Vision Care (HLAKAKAA)

Keywords

• Ophthalmic surgical devices
• Intraocular lenses
• Contact lenses
• Eye care pharmaceuticals
• Cataract surgery equipment

Headquarters

HQ city

Vernier

HQ country

Switzerland

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Surgical Products: Revenue from ophthalmic surgical products including implantables (IOLs), consumables, and surgical equipment. Net sales of $1.46 billion in Q1 2026.
2. Vision Care Products: Revenue from contact lenses and ocular health products including dry eye treatments, lens care solutions, and allergy drops. Net sales of $1.225 billion in Q1 2026.
3. Implantables: Intraocular lenses (IOLs) including Clareon, PanOptix, and Vivity families sold to surgical facilities and ophthalmologists
4. Contact Lenses: Daily disposable, reusable, and color-enhancing contact lenses sold through eye care professionals and direct-to-consumer channels

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Alcon is a global eye care company that develops, manufactures, and sells ophthalmic surgical products (intraocular lenses, phacoemulsification systems, vitreoretinal equipment, glaucoma devices, refractive surgery lasers) and vision care products (contact lenses, dry eye treatments, allergy drops, lens care solutions). The portfolio spans two segments — Surgical and Vision Care — and serves eye care professionals (surgeons, ophthalmologists, optometrists) and patients/consumers in more than 140 countries.

Product overview

Alcon offers a comprehensive eye care portfolio organized into two core business segments: Surgical and Vision Care. The Surgical segment includes advanced technology intraocular lenses (ATIOLs) such as Clareon TruPlus, PanOptix Pro, PanOptix, and Vivity; surgical equipment platforms including Unity CS/VCS, CENTURION, and CONSTELLATION; visualization systems like NGENUITY 3D; glaucoma devices including Hydrus Microstent and Belkin Vision DSLT; refractive surgery technologies (WaveLight, LenSx); and the ORA SYSTEM and ARGOS Biometer for surgical planning. The Vision Care segment encompasses contact lenses (TOTAL30, PRECISION1, DAILIES TOTAL1, AIR OPTIX families), ocular health products (Systane, Pataday, Tryptyr, EYSUVIS), and lens care solutions (OPTI-FREE, CLEAR CARE). Supporting offerings include the Fidelis VR surgical simulator and MARLO patient app. The portfolio serves patients across cataracts, glaucoma, retinal diseases, refractive errors, dry eye, and contact lens categories.

Differentiator

Problem solved

Functional benefit

Brands

• CLAREON: Family of intraocular lenses (IOLs) including monofocal, toric, and presbyopia-correcting options.
• SYSTANE
• TOTAL30
• PRECISION1
• PRECISION7
• DAILIES TOTAL1
• AIR OPTIX
• OPTIFREE
• Pataday
• Hydrus Microstent
• Unity
• PanOptix
• Vivity
• CENTURION
• CONSTELLATION
• NGENUITY
• WaveLight
• Tryptyr

Products and services

• Clareon TruPlus IOL Enhanced design monofocal and toric intraocular lens (IOL) featuring proprietary Opti-Balance Technology to increase depth of focus while maintaining high-quality distance vision, intended for ophthalmic surgeons performing cataract surgery.
• Unity CS Cataract System Next-generation standalone cataract surgical platform featuring novel phacoemulsification technology delivering up to 2x faster nucleus removal with 40% less energy into the eye, with a first-of-its-kind phaco handpiece that estimates temperature at the incision site, for cataract surgeons.
• Unity VCS Cataract Platform Cataract surgical platform featuring phacoemulsification technology for improved surgical outcomes, supporting cataract surgery workflow.
• PanOptix Trifocal IOL First and only trifocal intraocular lens in the U.S., the world's most implanted trifocal IOL with over 4 million implants, designed for cataract surgeons treating presbyopia during cataract surgery.
• PanOptix Pro IOL Presbyopia-correcting trifocal intraocular lens, next generation of the PanOptix family for cataract surgery.
• Vivity IOL Extended depth of focus IOL, the leading EDoF lens with over 2 million implants, offering wavefront-shaping presbyopia correction for cataract surgery patients.
• AcrySof IQ IOL First intraocular lens with material developed specifically for IOL implantation, FDA-approved in 1994, used by ophthalmologists for cataract surgery.
• CENTURION Vision System Alcon's most advanced phacoemulsification technology platform for cataract surgery, launched in 2013.
• CONSTELLATION Vision System Vitreoretinal surgery system used by retinal surgeons for retinal procedures.
• NGENUITY 3D Visualization System

Quantifiable outcome

• 2x faster nucleus removal with 40% less energy vs OZIL Torsional phaco (Unity CS)
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Seven partnerships are on record, tiered major and minor.

• Orbis InternationalmajorStrategic or Co-development Partner · 14 June 2026Long-standing partnership spanning over 40 years supporting Orbis Flying Eye Hospital programs. Alcon provides product donations, equipment, and expertise to expand access to eye care in underserved regions including Peru, Senegal, and Mongolia. The partnership includes a five-year national collaboration with the Ministry of Health.
• PerZeption Inc.minorStrategic or Co-development Partner · 2 May 2026Collaboration to present new data validating AIM+ CSF modeling technology at ARVO annual meeting in May 2026. The technology enables rapid, repeatable contrast vision assessment for vision correction assessment.
• Toronto Blue JaysminorGTM or Marketing Partner · 7 April 2026Systane partnership making it the official eye drop of the team, raising awareness about dry eye among Canadians with stadium activations and digital initiatives.
• Parrot AnalyticsminorStrategic or Co-development Partner · 1 April 2026Strategic partnership for Alcon Media Group integrating global cross-platform entertainment analytics and content valuation for IP investment strategy and talent planning.
• Glaucoma Research FoundationminorGTM or Marketing Partner · 9 March 2026Partnership to expand access to glaucoma education resources in Spanish in the United States, serving Spanish-speaking and visually impaired patients at higher risk for glaucoma.
• Laurel Surgical FoundationminorStrategic or Co-development PartnerPartnership supporting volunteer surgical missions including Mongolia trip where 127 cataract surgeries were performed. Alcon Canada associates volunteered alongside the surgical team.
• Plastic BankminorStrategic or Co-development PartnerPartnership since 2022 to build recycling ecosystems in underdeveloped communities and offset plastic used in select Alcon Surgical and Vision Care products.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Carl Zeiss Meditec: Zeiss Meditec manufactures ophthalmic surgical microscopes, IOLs (CT LUCIA, AT ELANA), and surgical equipment — competing directly with Alcon's CENTURION/Unity platforms and IOL franchises in surgical suites.
• CooperVision: CooperVision is a global contact lens specialist with daily, two-week, and monthly silicone hydrogel lenses (MyDay, clariti, Biofinity), competing head-to-head with Alcon's DAILIES TOTAL1, PRECISION, and AIR OPTIX families.
• Bausch + Lomb: Bausch + Lomb is a comprehensive eye care company with overlapping Surgical and Vision Care portfolios including IOLs, contact lenses (Biotrue), ophthalmic pharmaceuticals, and surgical equipment — making it Alcon's closest end-to-end competitor across both segments.
• Glaukos Corporation: Glaukos pioneered MIGS devices (iStent) for glaucoma and competes directly with Alcon's Hydrus Microstent in the minimally invasive glaucoma surgery market — overlapping Surgical segment customers and clinical use cases.
• Sight Sciences: Sight Sciences develops MIGS devices (OMNI) and dry eye products (TearCare) — overlapping with Alcon's Hydrus Microstent glaucoma franchise and Systane/Tryptyr dry eye portfolio, and a direct IP litigant against Alcon.
• HOYA Corporation: HOYA Surgical Optics manufactures IOLs (Vivinex, iSert) and competes with Alcon in the cataract surgery IOL market, while HOYA Vision Care produces eyeglass lenses — overlapping both of Alcon's primary segments.
• Johnson & Johnson Vision: J&J Vision (Acuvue, TECNIS IOLs, iDesign LASIK) competes directly with Alcon in daily disposable contact lenses, premium IOLs, and refractive surgery — overlapping core Vision Care and Surgical categories.
• STAAR Surgical: STAAR Surgical makes Implantable Collamer Lenses (ICL) for refractive vision correction and competed as an acquisition target for Alcon's refractive expansion; comparable as a fellow ophthalmic implantable lens specialist.
• LENSAR: LENSAR makes femtosecond laser cataract surgery systems (ALLY) and was Alcon's terminated acquisition target — directly competing in the same femto cataract surgery category where the FTC blocked Alcon's M&A.

Broad incumbents

• Topcon Corporation: Topcon is a broader ophthalmic diagnostic and imaging equipment maker (OCT, fundus cameras, refractive systems) overlapping with Alcon's surgical visualization and diagnostic-adjacent offerings within the same surgical suites.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/alcon
• Facebookfacebook.com/AlconEyeCare

Compliance39 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Subsidiaries9 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A17 records

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alcon